Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gemmill

Showing results (1-10 of 104) with videos related to

Pageof 11
Sort By:
Medical Examiner (Philadelphia, Pa.)|December 20, 2023
Singular Case of Death Occurring Twenty-two Days after Instrumental DeliveryJ M Gemmill
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 31, 2006
Mumps vaccine: is it time to re-evaluate our approach?Ian M Gemmill
Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC|November 26, 2019
How pharmacists are improving immunization in CanadaI M Gemmill
Advances in Cancer Research|April 20, 2010
Obesity, cholesterol, and clear-cell renal cell carcinoma (RCC)Harry A Drabkin, Robert M Gemmill
Canadian Medical Association Journal|June 15, 1983
Feasibility of prophylaxis against meningitis caused by Haemophilus influenzaeS J Corber, I M Gemmill
Cytogenetics and Cell Genetics|January 1, 1991
Report of the Second International Workshop on Human Chromosome 3 mappingR M Gemmill, H A Drabkin
Current Opinion in Pharmacology|September 4, 2012
Cholesterol and the development of clear-cell renal carcinomaHarry A Drabkin, Robert M Gemmill
Cancers|July 5, 2017
Epigenetic Regulation of the Epithelial to Mesenchymal Transition in Lung CancerJoëlle Roche, Robert M Gemmill, Harry A Drabkin
Oncotarget|December 13, 2017
A triad of NRP2, DLX and p53 proteins in lung cancer metastasisHarry A Drabkin, Julia Starkova, Robert M Gemmill
Oncotargets and Therapy|October 7, 2014
The emerging role of class-3 semaphorins and their neuropilin receptors in oncologyPatrick Nasarre, Robert M Gemmill, Harry A Drabkin
Pageof 11

Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
Medical Examiner (Philadelphia, Pa.)|December 20, 2023
Singular Case of Death Occurring Twenty-two Days after Instrumental DeliveryJ M Gemmill
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 31, 2006
Mumps vaccine: is it time to re-evaluate our approach?Ian M Gemmill
Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC|November 26, 2019
How pharmacists are improving immunization in CanadaI M Gemmill
Advances in Cancer Research|April 20, 2010
Obesity, cholesterol, and clear-cell renal cell carcinoma (RCC)Harry A Drabkin, Robert M Gemmill
Canadian Medical Association Journal|June 15, 1983
Feasibility of prophylaxis against meningitis caused by Haemophilus influenzaeS J Corber, I M Gemmill
Cytogenetics and Cell Genetics|January 1, 1991
Report of the Second International Workshop on Human Chromosome 3 mappingR M Gemmill, H A Drabkin
Current Opinion in Pharmacology|September 4, 2012
Cholesterol and the development of clear-cell renal carcinomaHarry A Drabkin, Robert M Gemmill
Cancers|July 5, 2017
Epigenetic Regulation of the Epithelial to Mesenchymal Transition in Lung CancerJoëlle Roche, Robert M Gemmill, Harry A Drabkin
Oncotarget|December 13, 2017
A triad of NRP2, DLX and p53 proteins in lung cancer metastasisHarry A Drabkin, Julia Starkova, Robert M Gemmill
Oncotargets and Therapy|October 7, 2014
The emerging role of class-3 semaphorins and their neuropilin receptors in oncologyPatrick Nasarre, Robert M Gemmill, Harry A Drabkin
Pageof 11